This content is Free Access.
Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma
章
- 00:05標題
- 01:35Assembling the Tumor Treating Fields System
- 02:49Applying the Transducer Arrays to the Scalp
- 04:11Results: Patient Treated with Tumor Treating Field Therapy with Bevacizumab
- 05:34Conclusion
A novel methodology that is employed for the treatment of recurrent glioblastomas is described. This treatment approach employs the application of alternating electric tumor treating fields (TTFields), known as TTF Therapy in combination with bevacizumab, a targeted agent that is currently FDA approved as monotherapy.
